170
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Re-Defining High Risk COPD with Parameter Response Mapping Based on Machine Learning Models

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 2471-2483 | Received 21 Apr 2022, Accepted 21 Jul 2022, Published online: 04 Oct 2022

References

  • GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1736–1788.
  • Rabe KF, Watz H. Chronic obstructive pulmonary disease. Lancet. 2017;389(10082):1931–1940.
  • Celli BR, Agustí A. COPD: time to improve its taxonomy? ERJ Open Res. 2018;4(1):00132–2017.
  • Koo HK, Vasilescu DM, Booth S, et al. Small airways disease in mild and moderate chronic obstructive pulmonary disease: a cross-sectional study. Lancet Respir Med. 2018;6(8):591–602.
  • Jobst BJ, Weinheimer O, Buschulte T, et al. Longitudinal airway remodeling in active and past smokers in a lung cancer screening population. Eur Radiol. 2019;29(6):2968–2980.
  • Takayanagi S, Kawata N, Tada Y, et al. Longitudinal changes in structural abnormalities using MDCT in COPD: do the CT measurements of airway wall thickness and small pulmonary vessels change in parallel with emphysematous progression? Int J Chron Obstruct Pulmon Dis. 2017;12:551–560.
  • Guan ZHUBJ. HB. The application of quantitative CT in the diagnosis and treatment of COPD. J Pract Radio. 2018;34:1994.
  • Regan EA, Lynch DA, Curran-Everett D, et al. Clinical and radiologic disease in smokers with normal spirometry. JAMA Intern Med. 2015;175(9):1539–1549.
  • Çolak Y, Afzal S. Prognostic significance of chronic respiratory symptoms in individuals with normal spirometry. Eur Respir J. 2020;55(1):1902226.
  • Woodruff PG, Barr RG, Bleecker E, et al. Clinical significance of symptoms in smokers with preserved pulmonary function. N Engl J Med. 2016;374(19):1811–1821.
  • Chen S, Wang C, Li B, et al. Risk factors for FEV1 decline in mild COPD and high-risk populations. Int J Chron Obstruct Pulmon Dis. 2017;12:435–442.
  • Wan ES, Castaldi PJ, Cho MH, et al. Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene. Respir Res. 2014;15(1):89.
  • Xia Y, Guan Y, Fan L, et al. Dynamic contrast enhanced magnetic resonance perfusion imaging in high-risk smokers and smoking-related COPD: correlations with pulmonary function tests and quantitative computed tomography. COPD. 2014;11(5):510–520.
  • Fan L, Xia Y, Guan Y, et al. Capability of differentiating smokers with normal pulmonary function from COPD patients: a comparison of CT pulmonary volume analysis and MR perfusion imaging. Eur Radiol. 2013;23(5):1234–1241.
  • Kirby M, Yin Y, Tschirren J, et al. A novel method of estimating small airway disease using inspiratory-to-expiratory computed tomography. Respiration. 2017;94(4):336–345.
  • Galbán CJ, Han MK, Boes JL, et al. Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression. Nat Med. 2012;18(11):1711–1715.
  • Pedregosa F, Varoquaux G, Gramfort A, et al. Scikit-learn: machine learning in Python. J Machine Res. 2011;12:2825–2830.
  • Stringer WW, Porszasz J, Bhatt SP, McCormack MC, Make BJ, Casaburi R. Physiologic insights from the COPD genetic epidemiology study. Chronic Obstr Pulm Dis. 2019;6(3):256–266.
  • Young KA, Strand M, Ragland MF, et al. Pulmonary subtypes exhibit differential global initiative for chronic obstructive lung disease spirometry stage progression: the COPDGene® study. Chronic Obstr Pulm Dis. 2019;6(5):414–429.
  • Lowe KE, Regan EA, Anzueto A, et al. COPDGene® 2019: redefining the diagnosis of chronic obstructive pulmonary disease. Chronic Obstr Pulm Dis. 2019;6(5):384–399.
  • Balkissoon R. Journal Club-COPD2020 update. global initiative for chronic obstructive lung disease 2020 report and the journal of the COPD foundation special edition, moving to a new definition for COPD: ”COPDGene® 2019”. Chronic Obstr Pulm Dis. 2019;6(4):64–72.
  • Bhatt SP, Soler X, Wang X, et al. Association between functional small airway disease and FEV1 decline in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2016;194(2):178–184.
  • Kim SJ, Lee J, Park YS, et al. Age-related annual decline of lung function in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2015;11:51–60.
  • Grabicki M, Kuźnar-Kamińska B, Rubinsztajn R, et al. COPD course and comorbidities: are there gender differences? Adv Exp Med Biol. 2019;1113:43–51.
  • Zhou Y, Wang D, Liu S, et al. The association between BMI and COPD: the results of two population-based studies in Guangzhou, China. COPD. 2013;10(5):567–572.
  • Ran PX, Wang C, Yao WZ, et al. A study on the correlation of body mass index with chronic obstructive pulmonary disease and quality of life. Zhonghua Jie He He Hu Xi Za Zhi. 2007;30(1):18–22.